Long-term follow-up of different refractory systemic vasculitides treated with rituximab

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis

(2009) Rachel B. Jones et al.   ARTHRITIS AND RHEUMATISM

Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis

(2009) Simon R. J. Taylor et al.   ARTHRITIS AND RHEUMATISM

B-cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort study

(2009) M. Martinez Del Pero et al.   CLINICAL OTOLARYNGOLOGY

Rituximab as rescue therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis: a single-centre experience with 15 patients

(2008) S. Lovric et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION